Anti-TrkB antibodies
US8642035B2 · kind B2 · utility
61Cited by
0References
31Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 16, 2009 |
| Grant date | Feb 4, 2014 |
| Priority date | — |
| Expiry date | May 19, 2030 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides improved antibodies or antigen-binding molecules that specifically recognize and agonize the tyrosine receptor kinase B (TrkB) receptor, and methods of their use. Also provided in the invention are polynucleotides and vectors that encode such molecules and host cells that harbor the polynucleotides or vectors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.